Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma.
Teele KuuskRoderick De BruijnOscar R BrouwerJeroen De JongMaarten DonswijkKees HendricksenSimon HorenblasKatarzyna JóźwiakWarner PrevooRenato A Valdés OlmosHenk G Van Der PoelBas Wg Van RhijnEsther M WitAxel BexPublished in: Scandinavian journal of urology (2018)
The rate of occult metastatic SN is low, but long disease-free survival (DFS) was observed in two patients with occult SN metastases. We hypothesize an interaortocaval lymphatic route in thoracic recurrences. Evaluation of the prognostic and therapeutic role of sentinel lymph node biopsy (SLNB) requires a clinical trial in high-risk RCC.
Keyphrases
- sentinel lymph node
- free survival
- lymph node
- metastatic renal cell carcinoma
- clinical trial
- early stage
- neoadjuvant chemotherapy
- ultrasound guided
- fine needle aspiration
- squamous cell carcinoma
- small cell lung cancer
- spinal cord
- open label
- phase ii
- study protocol
- locally advanced
- double blind
- randomized controlled trial
- phase iii
- radiation therapy
- rectal cancer